Vaccine manufacturer Serum Institute of India said on 29 September 2020 that it would get a further USD150m in funding from the Bill & Melinda Gates Foundation and the GAVI vaccines alliance to make an additional 100 million COVID-19 vaccine doses, Reuters news agency reported on Tuesday.
These additional doses are for India and other low-income and middle-income countries in 2021.
Reportedly, this collaboration builds upon an initial agreement signed in August 2020 by the company with the GAVI alliance and the Gates Foundation, with the total number of vaccine doses to be covered by the partnership amounting to 200 million.
Danaher Corporation announces quarterly cash dividend
Abbott announces quarterly common dividend
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva